PPLPHARMA vs MITTAL: Stock Comparison
Head-to-head financial and trading comparison between Piramal Pharma Limited (PPLPHARMA) and Mittal Life Style Limited (MITTAL) in the Cross-Sector Peers sector.
PPLPHARMA
NSE: PPLPHARMAMITTAL
NSE: MITTALKey Metrics Comparison Table
| Metric | PPLPHARMA | MITTAL | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹196.88 | ₹0.70 | — |
| 1-Year Price Return | +32.32% | -26.32% | PPLPHARMA (58.64% higher) |
| 52-Week High | ₹226.62 | ₹1.13 | — |
| 52-Week Low | ₹148.79 | ₹0.69 | — |
| 30-Day Annualized Volatility | 32.84% | 59.86% | PPLPHARMA (Steadier) |
| 30-Day Average Daily Volume | 3,775,308 | 1,962,032 | PPLPHARMA (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between PPLPHARMA and MITTAL, which stock gave better returns over the last year?
PPLPHARMA has outperformed MITTAL over the past 12 months with a gain of 32.32% compared to -26.32%.
Which stock is less volatile: PPLPHARMA or MITTAL?
PPLPHARMA demonstrated lower price volatility (32.84% annualized) compared to MITTAL (59.86%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of PPLPHARMA vs MITTAL?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are PPLPHARMA and MITTAL direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.